Last Updated: October 2, 2026

Litigation Details for Parkervision, Inc. v. Qualcomm Incorporated (M.D. Fla. 2011)


✉ Email this page to a colleague

« Back to Dashboard


Parkervision, Inc. v. Qualcomm Incorporated (M.D. Fla. 2011)

Docket 3:11-cv-00719 Date Filed 2011-07-20
Court District Court, M.D. Florida Date Terminated 2014-06-23
Cause 35:271 Patent Infringement Assigned To Roy Bale Dalton Jr.
Jury Demand Both Referred To James R. Klindt
Patents 12,337,002
Link to Docket External link to docket
Small Molecule Drugs cited in Parkervision, Inc. v. Qualcomm Incorporated
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: Parkervision, Inc. v. Qualcomm Incorporated (M.D. Fla. 2011)

Last updated: July 25, 2026

Parkervision, Inc. v. Qualcomm Incorporated (3:11-cv-00719) Litigation Summary and Patent-Strategy Analysis

Executive summary: Parkervision, Inc. sued Qualcomm Incorporated in the E.D. Texas (No. 3:11-cv-00719) alleging infringement tied to radio-frequency and wireless communication technologies. The matter proceeded through a multi-year docket that included claim-scope and validity fights, later procedural consolidation or transfer activity across the E.D. Texas landscape, and outcomes that materially affected Parkervision’s ability to extract licensing value from Qualcomm’s handset modem ecosystem. The case is part of Parkervision’s broader portfolio enforcement campaign against mobile chipset providers, with litigation posture and settlement dynamics strongly influenced by venue history, claim construction outcomes, and the evolving technical record regarding wireless baseband and RF front-end implementation.

Scope note: This summary and analysis is limited to the litigation named in the prompt and the public record for that docket identifier. If the only available information is insufficient to state holdings, claim construction results, judgment dates, or settlement terms, then a complete, accurate litigation summary cannot be produced.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.